1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Regorafenib’s evolving market is shaped by innovation, increasing generic adoption, and shifting global supply chain dynamics, placing healthcare providers and industry leaders at the front line of therapeutic advancements and competitive positioning.
Market Snapshot: Regorafenib Market Overview
The regorafenib market is a critical component of the oncology therapeutics landscape, serving advanced malignancy treatment needs across multiple regions. Recent years have seen this multi-kinase inhibitor become foundational in targeted therapies, expanding beyond initial indications such as colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. Factors such as expanding patient access, diverse formulation options, and regional differences in healthcare infrastructure are influencing current and future industry dynamics.
Scope & Segmentation
This research provides actionable intelligence across the regorafenib value chain, enabling executives to assess strategic opportunities within:
- Indications:
- First, second, and third-line colorectal cancer therapy
- Gastrointestinal stromal tumors
- Hepatocellular carcinoma
- Product Types:
- Branded
- Generic
- Distribution Channels:
- Hospital pharmacy
- Online pharmacy
- Retail pharmacy
- Clinic distribution
- Home delivery
- End Users:
- Academic hospitals
- Community hospitals
- Cancer centers
- Oncology clinics
- Retail pharmacies
- Online pharmacies
- Dosage Forms:
- Capsule
- Tablet
- Route of Administration:
- Oral
- Intravenous
- Regions Covered:
- Americas (United States, Canada, Mexico, Brazil, Argentina)
- Europe, Middle East & Africa (key markets in Western and Eastern Europe, GCC, and sub-Saharan Africa)
- Asia Pacific (China, India, Japan, Australia, South Korea, and Southeast Asia)
- Leading Companies:
- Bayer AG
- Viatris Inc.
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Cipla Ltd.
- Sandoz International GmbH
- Accord Healthcare Inc.
- Alembic Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
Key Takeaways: Regorafenib Market for Senior Decision-Makers
- Regorafenib is transitioning beyond refractory oncology settings as new evidence supports earlier-line usage and expanded indications.
- Generic entrants are accelerating market democratization, intensifying competitive dynamics and prompting differentiation in support services among originators.
- Digital health and real-world evidence platforms are redefining patient selection, adherence monitoring, and outcome optimization across patient populations.
- Strategic alliances are unlocking new efficiency in manufacturing and distribution, particularly in response to evolving global regulatory requirements and market demand.
- Distribution channel diversification—especially the rise of direct-to-patient and telehealth-enabled pathways—is extending access to treatment and reshaping commercial models.
- Regional variations in adoption highlight the importance of tailored market entry strategies, aligning pharmaceutical offerings with diverse reimbursement landscapes and regulatory pathways.
Tariff Impact
Recent changes to United States tariff policies have introduced new cost and supply chain complexities for the regorafenib market. Manufacturers are responding by diversifying procurement, increasing domestic capabilities, and reassessing inventory strategies. These adaptations are influencing pricing, negotiation with payers, and partnerships among specialty and digital pharmacy channels to mitigate margin pressures and ensure supply resiliency.
Methodology & Data Sources
This analysis integrates qualitative interviews with oncology experts, key opinion leaders, and supply chain stakeholders across North America, Europe, and Asia Pacific. Rigorous secondary research draws from regulatory documents, peer-reviewed journals, market intelligence, and legislative archives. Data triangulation and analytical modeling reinforce reliability and objectivity throughout the research process.
Why This Report Matters
- Provides C-suite executives with comprehensive insight to optimize commercial strategies for regorafenib products in mature and emerging markets.
- Equips teams to anticipate the impact of economic, regulatory, and technological shifts on both product differentiation and patient access frameworks.
- Enables evidence-based decision-making to navigate evolving reimbursement environments and capitalize on supply chain innovations.
Conclusion
Senior leaders who act on these insights will position their organizations for resilience, patient-centric value, and sustainable growth in the complex regorafenib market. Ongoing monitoring of policy and technology trends is recommended to maintain competitive advantage.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory approval of regorafenib in novel tumor indications expands market potential
5.2. Emergence of biosimilar competition intensifies pricing pressure in key regions
5.3. Integration of biomarker-driven patient selection improving treatment outcomes
5.4. Real world evidence studies demonstrating regorafenib survival benefits in mCRC patients
5.5. Strategic partnerships between pharmaceutical companies and diagnostics firms accelerate personalized therapy development
5.6. Health economic assessments supporting regorafenib cost effectiveness in colorectal cancer
5.7. Adoption of digital monitoring tools enhances patient adherence to regorafenib regimens
5.8. Supply chain challenges and raw material shortages impact regorafenib manufacturing timelines
5.2. Emergence of biosimilar competition intensifies pricing pressure in key regions
5.3. Integration of biomarker-driven patient selection improving treatment outcomes
5.4. Real world evidence studies demonstrating regorafenib survival benefits in mCRC patients
5.5. Strategic partnerships between pharmaceutical companies and diagnostics firms accelerate personalized therapy development
5.6. Health economic assessments supporting regorafenib cost effectiveness in colorectal cancer
5.7. Adoption of digital monitoring tools enhances patient adherence to regorafenib regimens
5.8. Supply chain challenges and raw material shortages impact regorafenib manufacturing timelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Regorafenib Drugs Market, by Indication
8.1. Introduction
8.2. Colorectal Cancer
8.2.1. First Line
8.2.2. Second Line
8.2.3. Third Line
8.3. Gastrointestinal Stromal Tumors
8.4. Hepatocellular Carcinoma
8.2. Colorectal Cancer
8.2.1. First Line
8.2.2. Second Line
8.2.3. Third Line
8.3. Gastrointestinal Stromal Tumors
8.4. Hepatocellular Carcinoma
9. Regorafenib Drugs Market, by Product Type
9.1. Introduction
9.2. Branded
9.3. Generic
9.2. Branded
9.3. Generic
10. Regorafenib Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Direct To Patient
10.2.1. Clinic Distribution
10.2.2. Home Delivery
10.3. Hospital Pharmacy
10.4. Online Pharmacy
10.5. Retail Pharmacy
10.2. Direct To Patient
10.2.1. Clinic Distribution
10.2.2. Home Delivery
10.3. Hospital Pharmacy
10.4. Online Pharmacy
10.5. Retail Pharmacy
11. Regorafenib Drugs Market, by End User
11.1. Introduction
11.2. Hospitals
11.2.1. Academic Hospitals
11.2.2. Community Hospitals
11.3. Online Pharmacies
11.4. Retail Pharmacies
11.5. Specialty Clinics
11.5.1. Cancer Centers
11.5.2. Oncology Clinics
11.2. Hospitals
11.2.1. Academic Hospitals
11.2.2. Community Hospitals
11.3. Online Pharmacies
11.4. Retail Pharmacies
11.5. Specialty Clinics
11.5.1. Cancer Centers
11.5.2. Oncology Clinics
12. Regorafenib Drugs Market, by Dosage Form
12.1. Introduction
12.2. Capsule
12.3. Tablet
12.2. Capsule
12.3. Tablet
13. Regorafenib Drugs Market, by Route Of Administration
13.1. Introduction
13.2. Intravenous
13.3. Oral
13.2. Intravenous
13.3. Oral
14. Americas Regorafenib Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Regorafenib Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Regorafenib Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bayer AG
17.3.2. Viatris Inc.
17.3.3. Dr. Reddy's Laboratories Ltd.
17.3.4. Sun Pharmaceutical Industries Ltd.
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Cipla Ltd.
17.3.7. Sandoz International GmbH
17.3.8. Accord Healthcare Inc.
17.3.9. Alembic Pharmaceuticals Ltd.
17.3.10. Intas Pharmaceuticals Ltd.
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bayer AG
17.3.2. Viatris Inc.
17.3.3. Dr. Reddy's Laboratories Ltd.
17.3.4. Sun Pharmaceutical Industries Ltd.
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Cipla Ltd.
17.3.7. Sandoz International GmbH
17.3.8. Accord Healthcare Inc.
17.3.9. Alembic Pharmaceuticals Ltd.
17.3.10. Intas Pharmaceuticals Ltd.
List of Figures
FIGURE 1. REGORAFENIB DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL REGORAFENIB DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. REGORAFENIB DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. REGORAFENIB DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. REGORAFENIB DRUGS MARKET: RESEARCHAI
FIGURE 28. REGORAFENIB DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. REGORAFENIB DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. REGORAFENIB DRUGS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL REGORAFENIB DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. REGORAFENIB DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. REGORAFENIB DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. REGORAFENIB DRUGS MARKET: RESEARCHAI
FIGURE 28. REGORAFENIB DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. REGORAFENIB DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. REGORAFENIB DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. REGORAFENIB DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL REGORAFENIB DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL REGORAFENIB DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY THIRD LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY THIRD LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY GASTROINTESTINAL STROMAL TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY GASTROINTESTINAL STROMAL TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HEPATOCELLULAR CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HEPATOCELLULAR CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CLINIC DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CLINIC DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOME DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOME DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 128. CANADA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 129. CANADA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 134. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 135. CANADA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. CANADA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. CANADA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. CANADA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. CANADA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. CANADA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 154. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 155. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 162. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 163. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 250. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 251. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 256. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 257. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 264. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 265. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 270. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 271. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 276. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 277. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. ITALY REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. ITALY REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. ITALY REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 310. ITALY REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 311. ITALY REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. ITALY REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 316. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 317. ITALY REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. ITALY REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. ITALY REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. ITALY REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. ITALY REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 322. ITALY REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 323. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 324. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 325. ITALY REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 326. ITALY REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 327. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 330. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 331. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 336. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 337. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 340. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 341. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 342. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 343. SPAIN REGORAF
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL REGORAFENIB DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL REGORAFENIB DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY THIRD LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY THIRD LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY GASTROINTESTINAL STROMAL TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY GASTROINTESTINAL STROMAL TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HEPATOCELLULAR CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HEPATOCELLULAR CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CLINIC DISTRIBUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CLINIC DISTRIBUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOME DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOME DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL REGORAFENIB DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES REGORAFENIB DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 128. CANADA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 129. CANADA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 134. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 135. CANADA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. CANADA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. CANADA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. CANADA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. CANADA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 142. CANADA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 143. CANADA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 154. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 155. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 162. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 163. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA REGORAFENIB DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 250. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 251. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 256. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 257. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 264. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 265. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. GERMANY REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 270. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 271. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 276. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 277. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. ITALY REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. ITALY REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. ITALY REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 310. ITALY REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 311. ITALY REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. ITALY REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 316. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 317. ITALY REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. ITALY REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. ITALY REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. ITALY REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. ITALY REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 322. ITALY REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 323. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 324. ITALY REGORAFENIB DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 325. ITALY REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 326. ITALY REGORAFENIB DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 327. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2018-2024 (USD MILLION)
TABLE 330. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY COLORECTAL CANCER, 2025-2030 (USD MILLION)
TABLE 331. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2018-2024 (USD MILLION)
TABLE 336. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY DIRECT TO PATIENT, 2025-2030 (USD MILLION)
TABLE 337. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 340. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 341. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 342. SPAIN REGORAFENIB DRUGS MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 343. SPAIN REGORAF
Samples
LOADING...
Companies Mentioned
The companies profiled in this Regorafenib Drugs Market report include:- Bayer AG
- Viatris Inc.
- Dr. Reddy's Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Cipla Ltd.
- Sandoz International GmbH
- Accord Healthcare Inc.
- Alembic Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
